Pain without Stain
The Elusive Neurotrophic Keratitis The cornea is the first line of defense of the eye, and as such is the most densely innervated and sensitive tissue in the body. With a central corneal nerve density of approximately 7,000 nociceptors per square millimeter the cornea is 300 to 600 times more sensitive than skin.1 These nerves play a vital… Read More
Neovascular AMD Management: What’s on the Horizon?
It was January 15th, 2005 when the FDA approved Macugen, the first anti-VEGF treatment for neovascular AMD (nAMD). Within 6 months, Phil Rosenfeld, MD, out of Bascom Palmer Eye Institute, published the first paper touting the efficacy of Avastin.1 Lucentis and Eylea became commercially available within the next 5 years, and treatment paradigms have witnessed… Read More
Northwest Eye Clinical Research Update: The Glaukos iDose GC-012 Study
Study Overview Northwest Eye Surgeons is happy to announce that Drs. Cameron and Kuzin are Principal Investigators in an active FDA approved Phase III clinical study on iDose Travoprost Intraocular Implants. This is a prospective, randomized masked three year study comparing novel implantable glaucoma medication delivery devices to topical timolol. One of two biocompatible… Read More
Post-Operative Hyphema
With the widespread adoption of clear corneal incisions during routine cataract surgery, little post-operative bleeding is expected during follow-up. However, when hyphema or bleeding into the anterior chamber is seen post-operatively it must be managed appropriately to minimize morbidity and promote visual recovery. The following article summarizes the causes of post-operative hyphema, suggests an approach… Read More
Angle Closure
According to the World Health Organization, glaucoma is the leading cause of preventable blindness worldwide. Glaucoma can be subdivided into two types based on anterior segment anatomy: open-angle glaucoma or angle-closure glaucoma. While open-angle glaucoma is the significantly more prevalent form of the two, angle-closure glaucoma is more likely to cause bilateral blindness. Angle closure… Read More
Where to Start with Plaquenil Screenings
Plaquenil (hydroxychloroquine) has been thrusted into the spotlight due to the current COVID-19 pandemic. Its off-label use has been used a potential therapy for the virus, all data being anecdotal at best. Before COVID-19, Plaquenil was first used as an anti-malarial, but quickly started being used for a myriad of autoimmune diseases. The anti-inflammatory effects… Read More
A Rare Case of Nevus of Ota
Paul Krabill, OD, partnered in authoring the article “A Rare Case of Nevus of Ota,” in the current issue of the Review of Optometry. The article “reviews a Caucasian patient with primary choroidal melanoma presented with a surprising underlying diagnosis.” This was a case report submitted through the Larry Alexander Case Report contest sponsored by the Optometric Retina… Read More
LASIK & SMILE: The Future is Bright with a New Technology Option
Whether LASIK or SMILE is the laser vision correction best suited for your patients, their vision for the future can be sharpened. As you know, LASIK has been helping patients for more than 25 years to see more clearly without glasses. Today we want to tell you about the newest laser vision correction technology coming… Read More
The Best 30 Seconds of Your Patient’s Year
SMILE is at NWES and the vision options for your patients will never be the same! We couldn’t be more excited to offer SMILE laser technology at Northwest Eye Surgeons. Our doctors and team are confident the lives and vision of our patients will be changed through this new innovation in laser vision correction. It’s… Read More
Chronic Iritis with a Twist
Nearly four years ago, a 62 year old Asian man presented as a new patient for evaluation of blur in the left eye and pain in his left temple x1 day. He denied light sensitivity, history of shingles, history of oral ulcers. He had chickenpox as a child. He had a complicated ocular history in… Read More